生物
造血
移植
干细胞
免疫学
嵌合体(遗传学)
骨髓
癌症的体细胞进化
髓样
错义突变
遗传学
突变
基因
医学
内科学
作者
Miguel Ganuza,Trent Hall,David Finkelstein,Yong‐Dong Wang,Ashley Chabot,Guolian Kang,Wenjian Bi,Gang Wu,Shannon McKinney‐Freeman
出处
期刊:Blood
[American Society of Hematology]
日期:2019-05-02
卷期号:133 (18): 1927-1942
被引量:54
标识
DOI:10.1182/blood-2018-09-873059
摘要
Abstract Although many recent studies describe the emergence and prevalence of “clonal hematopoiesis of indeterminate potential” in aged human populations, a systematic analysis of the numbers of clones supporting steady-state hematopoiesis throughout mammalian life is lacking. Previous efforts relied on transplantation of “barcoded” hematopoietic stem cells (HSCs) to track the contribution of HSC clones to reconstituted blood. However, ex vivo manipulation and transplantation alter HSC function and thus may not reflect the biology of steady-state hematopoiesis. Using a noninvasive in vivo color-labeling system, we report the first comprehensive analysis of the changing global clonal complexity of steady-state hematopoiesis during the natural murine lifespan. We observed that the number of clones (ie, clonal complexity) supporting the major blood and bone marrow hematopoietic compartments decline with age by ∼30% and ∼60%, respectively. Aging dramatically reduced HSC in vivo–repopulating activity and lymphoid potential while increasing functional heterogeneity. Continuous challenge of the hematopoietic system by serial transplantation provoked the clonal collapse of both young and aged hematopoietic systems. Whole-exome sequencing of serially transplanted aged and young hematopoietic clones confirmed oligoclonal hematopoiesis and revealed mutations in at least 27 genes, including nonsense, missense, and deletion mutations in Bcl11b, Hist1h2ac, Npy2r, Notch3, Ptprr, and Top2b.
科研通智能强力驱动
Strongly Powered by AbleSci AI